Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Val-Cit-PAB-Exatecan (TFA)

Val-Cit-PAB-Exatecan (Val-Cit-PAB-DX8951) TFA is a agent-linker conjugate for ADC. Val-Cit-PAB-Exatecan TFA is composed of a DNA topoisomerase I DX-8951 (HY-13631) and a cathepsin cleavable ADC linker[1].

Product Specifications

CAS Number

[2928571-44-0]

Product Name Alternative

Val-Cit-PAB-DX8951 (TFA)

UNSPSC

12352203

Target

Drug-Linker Conjugates for ADC; Topoisomerase

Type

ADC Related

Related Pathways

Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/val-cit-pab-exatecan-tfa.html

Purity

99.73

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

CC(C)[C@H](N)C(N[C@@H](CCCNC(N)=O)C(NC(C=C1)=CC=C1COC(N[C@@H]2C3=C4C(C(N5C4)=CC([C@](O)(C(OC6)=O)CC)=C6C5=O)=NC7=CC(F)=C(C)C(CC2)=C73)=O)=O)=O.O=C(O)C(F)(F)F

Molecular Formula

C45H50F4N8O11

Molecular Weight

954.92

References & Citations

[1]Thomas A, et al. Antibody-drug conjugates for cancer therapy. Lancet Oncol. 2016 Jun;17 (6) :e254-e262.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C (Powder, sealed storage, away from moisture)

Scientific Category

ADC Related

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

GTF3C2 (KIAA0011, General Transcription Factor 3C Polypeptide 2, TF3C-beta, Transcription Factor IIIC 110kD Subunit, Transcription Factor IIIC Subunit beta)

127656 100 µg

GTF3C2 (KIAA0011, General Transcription Factor 3C Polypeptide 2, TF3C-beta, Transcription Factor IIIC 110kD Subunit, Transcription Factor IIIC Subunit beta)

Ask

Uap1l1 Rat shRNA Plasmid (Locus ID 296560)

TL708656 1 Kit

Uap1l1 Rat shRNA Plasmid (Locus ID 296560)

Ask

[1,1'-Biphenyl]-4-carboxylic Acid (3aR,4R,5R,6aS) -Hexahydro-4-[ (3R) -3-hydroxy-5-phenylpentyl]-2-oxo-2H-cyclopenta[b]furan-5-yl Ester

410522-01 1 mg

[1,1'-Biphenyl]-4-carboxylic Acid (3aR,4R,5R,6aS) -Hexahydro-4-[ (3R) -3-hydroxy-5-phenylpentyl]-2-oxo-2H-cyclopenta[b]furan-5-yl Ester

Ask

[1,1'-Biphenyl]-4-carboxylic Acid (3aR,4R,5R,6aS) -Hexahydro-4-[ (3R) -3-hydroxy-5-phenylpentyl]-2-oxo-2H-cyclopenta[b]furan-5-yl Ester

410522-02 5 mg

[1,1'-Biphenyl]-4-carboxylic Acid (3aR,4R,5R,6aS) -Hexahydro-4-[ (3R) -3-hydroxy-5-phenylpentyl]-2-oxo-2H-cyclopenta[b]furan-5-yl Ester

Ask

PI3K? inhibitor 4

MF-0000831-01 25 mg

PI3K? inhibitor 4

Ask

PI3K? inhibitor 4

MF-0000831-02 50 mg

PI3K? inhibitor 4

Ask